In Vivo Generation of Chimeric Antigen Receptor Cells to Treat Hemopoietic Malignancies

IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-PRESENT)

Ron Levy, MD, Stanford University School of Medicine

Dr. Levy is investigating a pre-clinical “off-the-shelf” CAR (chimeric antigen receptor) T-cell immunotherapy approach where the CAR cells are generated directly in the patient’s body.

BACK TO OUR PORTFOLIO